Európai Unió -
magyar -
EMA (European Medicines Agency)
sugammadex amomed
aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuszkuláris blokád - minden más terápiás készítmény - a rokuronium vagy a vekuronium által indukált neuromuszkuláris blokád visszafordítása. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.
Európai Unió -
magyar -
EMA (European Medicines Agency)
akeega
janssen-cilag international n.v. - abiraterone acetate, niraparib tosilate monohydrate - prosztata daganatok, kasztráció-rezisztens - daganatellenes szerek - treatment of adult patients with prostate cancer.
Európai Unió -
magyar -
EMA (European Medicines Agency)
talvey
janssen-cilag international n.v. - talquetamab - myeloma multiplex - daganatellenes szerek - talvey is indicated as monotherapy for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least 3 prior therapies, including an immunomodulatory agent, a proteasome inhibitor, and an anti cd38 antibody and have demonstrated disease progression on the last therapy.